The latest research from Fore Pharma, Global Melanoma Market and Competitive Landscape – 2020, provides comprehensive insights into Melanoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Melanoma market size and drug sales. It also provides insights into Melanoma epidemiology and late stage pipeline.
This research covers the following – Melanoma treatment options, Melanoma late stage clinical trials pipeline, Melanoma prevalence by countries, Melanoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Melanoma pipeline: Find out drugs in clinical trials for Melanoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Melanoma epidemiology: Find out number of patients diagnosed (prevalence) with Melanoma by countries
– Melanoma drugs: Identify key drugs marketed and prescribed for Melanoma by countries, including trade name, molecule name, and company
– Melanoma drugs sales: Find out the sales value for Melanoma drugs by countries
– Melanoma market valuations: Find out the market size for Melanoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Melanoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Melanoma drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Melanoma market
– Develop in-depth knowledge of competition and markets
– Analyze Melanoma drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Melanoma market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Melanoma Treatment Options
2. Melanoma Pipeline Insights
2.1. Melanoma Phase 3 Clinical Trials
2.2. Melanoma Phase 2 Clinical Trials
2.3. Melanoma Phase 1 Clinical Trials
3. Melanoma Epidemiology Analysis by Countries
4. US Melanoma Market Insights
4.1. Marketed Drugs for Melanoma in US
4.2. US Melanoma Market Size & Forecast
4.3. US Melanoma Drugs Sales & Forecast
4.4. US Melanoma Market Share Analysis
5. Germany Melanoma Market Insights
5.1. Marketed Drugs for Melanoma in Germany
5.2. Germany Melanoma Market Size & Forecast
5.3. Germany Melanoma Drugs Sales Forecast
5.4. Germany Melanoma Market Share Analysis
6. France Melanoma Market Insights
6.1. Marketed Drugs for Melanoma in France
6.2. France Melanoma Market Size & Forecast
6.3. France Melanoma Product Sales Forecast
6.4. France Melanoma Market Share Analysis
7. Italy Melanoma Market Insights
7.1. Marketed Drugs for Melanoma in Italy
7.2. Italy Melanoma Market Size & Forecast
7.3. Italy Melanoma Product Sales Forecast
7.4. Italy Melanoma Market Share Analysis
8. Spain Melanoma Market Insights
8.1. Marketed Drugs for Melanoma in Spain
8.2. Spain Melanoma Market Size & Forecast
8.3. Spain Melanoma Product Sales Forecast
8.4. Spain Melanoma Market Share Analysis
9. UK Melanoma Market Insights
9.1. Marketed Drugs for Melanoma in UK
9.2. UK Melanoma Market Size & Forecast
9.3. UK Melanoma Product Sales Forecast
9.4. UK Melanoma Market Share Analysis
10. Europe Melanoma Market Insights
10.1. Europe Melanoma Market Size & Forecast
10.2. Europe Melanoma Product Sales Forecast
10.3. Europe Melanoma Market Share Analysis
11. Japan Melanoma Market Insights
11.1. Marketed Drugs for Melanoma in Japan
11.2. Japan Melanoma Market Size & Forecast
11.3. Japan Melanoma Product Sales Forecast
11.4. Japan Melanoma Market Share Analysis
12. Global Melanoma Market Insights
12.1. Global Melanoma Market Size & Forecast
12.2. Global Melanoma Product Sales Forecast
12.3. Global Melanoma Market Share Analysis
13. Research Methodology
List of Tables
1: Melanoma Phase 3 Clinical Trials, Global, 2020
2: Melanoma Phase 2 Clinical Trials, Global, 2020
3: Melanoma Phase 1 Clinical Trials, Global, 2020
4: Melanoma Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Melanoma in US, 2019
6: US Melanoma Market Size & Forecast ($mn), 2016 – 2025
7: US Melanoma Product Sales ($mn), 2016 – 2025
8: US Melanoma Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Melanoma in Germany, 2019
10: Germany Melanoma Market Size & Forecast ($mn), 2016 – 2025
11: Germany Melanoma Product Sales ($mn), 2016 – 2025
12: Germany Melanoma Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Melanoma in France, 2019
14: France Melanoma Market Size & Forecast ($mn), 2016 – 2025
15: France Melanoma Product Sales ($mn), 2016 – 2025
16: France Melanoma Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Melanoma in Italy, 2019
18: Italy Melanoma Market Size & Forecast ($mn), 2016 – 2025
19: Italy Melanoma Product Sales ($mn), 2016 – 2025
20: Italy Melanoma Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Melanoma in Spain, 2019
22: Spain Melanoma Market Size & Forecast ($mn), 2016 – 2025
23: Spain Melanoma Product Sales ($mn), 2016 – 2025
24: Spain Melanoma Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Melanoma in UK, 2019
26: UK Melanoma Market Size & Forecast ($mn), 2016 – 2025
27: UK Melanoma Product Sales ($mn), 2016 – 2025
28: UK Melanoma Market Events and Trends, 2016 – 2025
29: Europe Melanoma Market Size & Forecast ($mn), 2016 – 2025
30: Europe Melanoma Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Melanoma in Japan, 2019
32: Japan Melanoma Market Size & Forecast ($mn), 2016 – 2025
33: Japan Melanoma Product Sales ($mn), 2016 – 2025
34: Japan Melanoma Market Events and Trends, 2016 – 2025
35: Global Melanoma Market Size & Forecast ($mn), 2016 – 2025
36: Global Melanoma Product Sales ($mn), 2016 – 2025
List of Figures
1: Melanoma Pipeline by Phase (%), Global, 2020
2: Melanoma Prevalence by Countries, 2016 – 2025
3: US Melanoma Market Size ($mn), 2016 – 2025
4: US Melanoma Product Sales ($mn), 2016 – 2025
5: US Melanoma Market Share by Drugs (%), 2019
6: US Melanoma Market – Future Market Share (%), 2025
7: Germany Melanoma Market Size ($mn), 2016 – 2025
8: Germany Melanoma Product Sales ($mn), 2016 – 2025
9: Germany Melanoma Market Share by Drugs (%), 2019
10: Germany Melanoma Market – Future Market Share (%), 2025
11: France Melanoma Market Size ($mn), 2016 – 2025
12: France Melanoma Product Sales ($mn), 2016 – 2025
13: France Melanoma Market Share by Drugs (%), 2019
14: France Melanoma Market – Future Market Share (%), 2025
15: Italy Melanoma Market Size ($mn), 2016 – 2025
16: Italy Melanoma Product Sales ($mn), 2016 – 2025
17: Italy Melanoma Market Share by Drugs (%), 2019
18: Italy Melanoma Market – Future Market Share (%), 2025
19: Spain Melanoma Market Size ($mn), 2016 – 2025
20: Spain Melanoma Product Sales ($mn), 2016 – 2025
21: Spain Melanoma Market Share by Drugs (%), 2019
22: Spain Melanoma Market – Future Market Share (%), 2025
23: UK Melanoma Market Size ($mn), 2016 – 2025
24: UK Melanoma Product Sales ($mn), 2016 – 2025
25: UK Melanoma Market Share by Drugs (%), 2019
26: UK Melanoma Market – Future Market Share (%), 2025
27: Europe Melanoma Market Size ($mn), 2016 – 2025
28: Europe Melanoma Product Sales ($mn), 2016 – 2025
29: Europe Melanoma Market Share by Drugs (%), 2019
30: Europe Melanoma Market – Future Market Share (%), 2025
31: Japan Melanoma Market Size ($mn), 2016 – 2025
32: Japan Melanoma Product Sales ($mn), 2016 – 2025
33: Japan Melanoma Market Share by Drugs (%), 2019
34: Japan Melanoma Market – Future Market Share (%), 2025
35: Global Melanoma Market Size ($mn), 2016 – 2025
36: Global Melanoma Product Sales ($mn), 2016 – 2025
37: Global Melanoma Market Share by Drugs (%), 2019
38: Global Melanoma Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.